Research & Development



  “不是,是我根據我山門總結出來的一些道理,運用到實際情況之中得出來的結果。”奇米影院   會說漢話的將庸笑道︰“汝昨夜安在?”奇米色   橘紅色的火焰照亮了曹襄的臉龐,眼看著那只肥碩的野雞滋滋的往下滴著油,曹襄急不可耐。   恨雲瑯的不僅僅是那群游俠,還有梁池,鐘離黃跟要擒,這三個家伙居然也淚流滿面,雖然還不至于對雲瑯咬牙切齒,也是神情不善。狠狠撸   雲瑯路過松林就是去拜訪張湯的。

Our discovery and development platforms for drug and cell-based therapies allow us to both create and retain significant value within our therapeutic franchise areas of cancer and inflammatory diseases. Scientists and physicians at Celgene are the driving force behind our success, enabling target-to-therapeutic platforms that integrate both small-molecule and cell-based therapies.

Connect? Registries

The Connect??Registries are observational, hematologic patient registry studies in Multiple Myeloma (Connect?MM), Chronic Lymphocytic Leukemia (Connect?CLL) and Myelodysplastic Syndromes/Acute Myeloid Leukemia (Connect?MDS/AML) and are sponsored by Celgene Corporation. These studies are designed to observe the routine care of patients through the course of their disease. Unlike clinical trials, registries do not require or provide any specific medications or healthcare services, but leave those decisions to the treating doctors and their patients.
Connect? Registries logo